| 1 |
angiotensin-converting enzyme 2
(4192 times)
|
Medicine
(364 times)
|
SARS-CoV-2 (1381 times)
COVID-19 (1014 times)
RBD (525 times)
|
2002 Angiotensin-converting enzyme 2 is an essential regulator of heart function.
|
| 2 |
Ang-converting enzyme 2
(8 times)
|
Physiology
(2 times)
|
Ang (4 times)
Ang II (2 times)
RAS (2 times)
|
2009 Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus.
|
| 3 |
angiotensin-converting enzyme-related carboxypeptidase 2
(4 times)
|
Water-Electrolyte Imbalance
(2 times)
|
Ang II (2 times)
AhR (1 time)
Ang (1 time)
|
2010 Maternal apelin physiology during rat pregnancy: the role of the placenta.
|
| 4 |
ACE type 2
(3 times)
|
Physiology
(2 times)
|
ACE (2 times)
Ang 1-7 (2 times)
Ang II (2 times)
|
2012 Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.
|
| 5 |
ACE2-gene network
(2 times)
|
Genetic Phenomena
(1 time)
|
GWAS (1 time)
|
2020 ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility.
|
| 6 |
ACE2 KI mice
(1 time)
|
Neurology
(1 time)
|
BLA (1 time)
EPM (1 time)
MasR (1 time)
|
2016 Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors.
|
| 7 |
ACE2 receptor
(1 time)
|
Biology
(1 time)
|
RBD (1 time)
RBM (1 time)
VOC (1 time)
|
2021 The SARS-CoV-2 spike protein is vulnerable to moderate electric fields.
|
| 8 |
ACE2-associated viruses
(1 time)
|
|
AKI (1 time)
CI (1 time)
COVID-19 (1 time)
|
2021 Acute Kidney Injury and Renal Replacement Therapy in COVID-19 Versus Other Respiratory Viruses: A Systematic Review and Meta-Analysis.
|
| 9 |
ACE2-Fc
(1 time)
|
|
RBDs (1 time)
SARS-CoV-2 (1 time)
|
2020 Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2.
|
| 10 |
ACE2-RBD
(1 time)
|
Medical Informatics
(1 time)
|
POMs (1 time)
TMPRSS2 (1 time)
|
2022 Can polyoxometalates (POMs) prevent of coronavirus 2019-nCoV cell entry? Interaction of POMs with TMPRSS2 and spike receptor domain complexed with ACE2 (ACE2-RBD): Virtual screening approaches.
|
| 11 |
ACE2/rMAS gene expression compared to the HF group
(1 time)
|
Gastrointestinal Diseases
(1 time)
|
ACE (1 time)
Ang II (1 time)
AT1r (1 time)
|
2019 Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model.
|
| 12 |
acetyl cholinesterase 2
(1 time)
|
Biotechnology
(1 time)
|
LOD (1 time)
POC (1 time)
RT-PCR (1 time)
|
2022 Point-of-care SARS-CoV-2 sensing using lens-free imaging and a deep learning-assisted quantitative agglutination assay.
|
| 13 |
acute respiratory syndrome coronavirus 2 receptor
(1 time)
|
Dentistry
(1 time)
|
COVID-19 (1 time)
|
2022 Porphyromonas gingivalis association with inflammatory markers and exosomal miRNA-155 in saliva of periodontitis patients with and without diabetes diagnosed with COVID-19.
|
| 14 |
AGS-ACE2
(1 time)
|
Microbiology
(1 time)
|
AGS (1 time)
CG (1 time)
RBD (1 time)
|
2021 Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.
|
| 15 |
Altimeter Corrected Elevations 2
(1 time)
|
Environmental Health
(1 time)
|
GDEM (1 time)
|
2011 Evaluation of the differences between the SRTM and satellite radar altimetry height measurements and the approach taken for the ACE2 GDEM in areas of large disagreement.
|
| 16 |
analyses, in male subjects the model of rs2106809
(1 time)
|
Endocrinology
(1 time)
|
RAS (1 time)
|
2010 Interactions among related genes of renin-angiotensin system associated with type 2 diabetes.
|
| 17 |
Analysis of the intermolecular interactions revealed that T27A
(1 time)
|
Computational Biology
(1 time)
|
COVID-19 (1 time)
RBD (1 time)
SARS-CoV-2 (1 time)
|
2021 Prediction of the Effects of Variants and Differential Expression of Key Host Genes ACE2, TMPRSS2, and FURIN in SARS-CoV-2 Pathogenesis: An In Silico Approach.
|
| 18 |
Angiotensin Converting Enzyme 2 Activity in Biological Fluid
(1 time)
|
Molecular Biology
(1 time)
|
ADAM17 (1 time)
Ang (1 time)
CVs (1 time)
|
2017 Measurement of Angiotensin Converting Enzyme 2 Activity in Biological Fluid (ACE2).
|
| 19 |
Angiotensin-converting accelerator 2
(1 time)
|
|
COVID-19 (1 time)
DM (1 time)
DPP4 (1 time)
|
2022 COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.
|
| 20 |
same cell entry receptor as SARS-CoV,angiotensin-converting enzyme 2
(1 time)
|
Biology
(1 time)
|
SARS-CoV-2 (1 time)
|
2020 Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.
|
| 21 |
system-RAAS-Angiotensin converting enzyme 2
(1 time)
|
Biology
(1 time)
|
ARDS (1 time)
CD147 (1 time)
COVID-19 (1 time)
|
2020 Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.
|
A Search Service for Abbreviation / Long Form